Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
First Online: 25 June 2025
Competing interests
: I.M. has grants funded by Genmab, AstraZeneca, Bristol Myers and Roche, and has received consultancy fees from Genmab, Pioneering Medicines, Curon, Pharmamar, Biontech, F-STAR, Numab, Light Chain, Bright Peaks, Roche and Mestag. C.L.-R. and Á.T. declare no competing interests.
